Hygeia Healthcare Holdings Co., Limited repurchased 388,400 ordinary shares on 22 July 2026 through the Hong Kong Stock Exchange, paying between HKD 10.24 and HKD 10.38 per share. The volume-weighted average consideration was HKD 10.30, bringing total outlay to approximately HKD 4.00 million. All repurchased shares are being held as treasury stock.

The buyback reduced the company’s issued share capital (excluding treasury shares) from 606.64 million to 606.25 million shares, a 0.064% contraction. Treasury shares increased from 11.86 million to 12.25 million, while total issued shares remained unchanged at 618.50 million.

The transaction forms part of the repurchase mandate approved on 26 June 2026, which authorises the company to buy back up to 60.77 million shares. Including the latest purchase, Hygeia Healthcare has repurchased 1.49 million shares under the mandate, equivalent to 0.2454% of the share count in place when the mandate was granted.

Pursuant to Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 21 August 2026.